Imaging and Physiologic Evaluation of Coronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorChonnam National University Hospital
About this trial
To evaluate the long-term clinical outcomes and prognostic factors in patients with coronary artery disease (CAD) undergoing invasive coronary angiography (ICA), intravascular imaging, or invasive physiologic assessment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subject must be at least 18 years of age
Subjects who suspected ischemic heart disease and underwent ICA.
Subjects who were performed intravascular imaging or invasive physiologic assessment
Disqualifiers
Subject with Age <18 years
Pregnant women
Trial population
About 2,000 patients with suspected ischemic heart disease and underwent ICA, intravascular imaging, or invasive physiologic assessment
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment
Diagnostic testIntravascular imaging (IVUS or OCT) or Invasive physiologic assessment
PCI
Procedure/SurgeryPatients who undergoing PCI
Treatment groups
2,000 Participants
are divided into 2 treatment groupsGroup A: Invasive coronary angiography (ICA)1 intervention
Group B: Percutaneous coronary intervention (PCI)2 interventions
Trial outcomes
Primary outcomes
1
MACE
a composite of all-cause death, myocardial infarction, or any revascularization
Time frame
3-Year after the index procedureSecondary outcomes
1
Rate of all-cause death
death from any-cause
Time frame
3-Year after the index procedure2
Rate of cardiac death
death from cardiac-cause
Time frame
3-Year after the index procedure3
Rate of myocardial infarction
Myocardial infarction without peri-procedural myocardial infarction
Time frame
3-Year after the index procedure4
Rate of target lesion revascularization
ischemia-driven or all
Time frame
3-Year after the index procedureSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov